212 related articles for article (PubMed ID: 30578919)
1. Concentrations of bile acid precursors in cerebrospinal fluid of Alzheimer's disease patients.
Griffiths WJ; Abdel-Khalik J; Yutuc E; Roman G; Warner M; Gustafsson JÅ; Wang Y
Free Radic Biol Med; 2019 Apr; 134():42-52. PubMed ID: 30578919
[TBL] [Abstract][Full Text] [Related]
2. Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma.
Abdel-Khalik J; Crick PJ; Yutuc E; DeBarber AE; Duell PB; Steiner RD; Laina I; Wang Y; Griffiths WJ
Biochimie; 2018 Oct; 153():86-98. PubMed ID: 29960034
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?
Ogundare M; Theofilopoulos S; Lockhart A; Hall LJ; Arenas E; Sjövall J; Brenton AG; Wang Y; Griffiths WJ
J Biol Chem; 2010 Feb; 285(7):4666-79. PubMed ID: 19996111
[TBL] [Abstract][Full Text] [Related]
4. Defective cholesterol metabolism in amyotrophic lateral sclerosis.
Abdel-Khalik J; Yutuc E; Crick PJ; Gustafsson JÅ; Warner M; Roman G; Talbot K; Gray E; Griffiths WJ; Turner MR; Wang Y
J Lipid Res; 2017 Jan; 58(1):267-278. PubMed ID: 27811233
[TBL] [Abstract][Full Text] [Related]
5. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
[TBL] [Abstract][Full Text] [Related]
6. Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients.
Crick PJ; Griffiths WJ; Zhang J; Beibel M; Abdel-Khalik J; Kuhle J; Sailer AW; Wang Y
Mol Neurobiol; 2017 Dec; 54(10):8009-8020. PubMed ID: 27878760
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
[TBL] [Abstract][Full Text] [Related]
8. CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls.
Biemans EA; Verhoeven-Duif NM; Gerrits J; Claassen JA; Kuiperij HB; Verbeek MM
Neurobiol Aging; 2016 Jun; 42():213-6. PubMed ID: 27143438
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
[TBL] [Abstract][Full Text] [Related]
10. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.
Begcevic I; Brinc D; Brown M; Martinez-Morillo E; Goldhardt O; Grimmer T; Magdolen V; Batruch I; Diamandis EP
J Proteomics; 2018 Jun; 182():12-20. PubMed ID: 29684683
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid in the dementias.
Zetterberg H; Rohrer JD; Schott JM
Handb Clin Neurol; 2017; 146():85-97. PubMed ID: 29110781
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
van Steenoven I; Majbour NK; Vaikath NN; Berendse HW; van der Flier WM; van de Berg WDJ; Teunissen CE; Lemstra AW; El-Agnaf OMA
Mov Disord; 2018 Nov; 33(11):1724-1733. PubMed ID: 30440090
[TBL] [Abstract][Full Text] [Related]
13. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
[TBL] [Abstract][Full Text] [Related]
14. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
Chaudhry A; Houlden H; Rizig M
J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
[TBL] [Abstract][Full Text] [Related]
15. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.
Vinceti M; Chiari A; Eichmüller M; Rothman KJ; Filippini T; Malagoli C; Weuve J; Tondelli M; Zamboni G; Nichelli PF; Michalke B
Alzheimers Res Ther; 2017 Dec; 9(1):100. PubMed ID: 29258624
[TBL] [Abstract][Full Text] [Related]
16. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
17. The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid.
Crick PJ; Beckers L; Baes M; Van Veldhoven PP; Wang Y; Griffiths WJ
Steroids; 2015 Jul; 99(Pt B):172-7. PubMed ID: 25759118
[TBL] [Abstract][Full Text] [Related]
18. Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
Minta K; Brinkmalm G; Portelius E; Johansson P; Svensson J; Kettunen P; Wallin A; Zetterberg H; Blennow K; Andreasson U
J Alzheimers Dis; 2021; 79(2):729-741. PubMed ID: 33337373
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer's disease.
Casoli T; Paolini S; Fabbietti P; Fattoretti P; Paciaroni L; Fabi K; Gobbi B; Galeazzi R; Rossi R; Lattanzio F; Pelliccioni G
J Int Med Res; 2019 Oct; 47(10):4968-4980. PubMed ID: 31524025
[TBL] [Abstract][Full Text] [Related]
20. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
